Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Los Angeles, California


Purpose:

This is an extension study for patients who have previously completed Idenix Study NV-02B-003. This study is being conducted to compare the safety and effectiveness of treatment beyond 1 year of telbivudine and telbivudine combined with lamivudine, a drug currently approved for the treatment of hepatitis B.


Criteria:

Inclusion Criteria: - Patient has completed protocol NV-02B-003 without a serious adverse event attributed to study drug - Patient remains seropositive for hepatitis B surface antigen (HBsAg) Other protocol-defined inclusion criteria may apply. Exclusion Criteria: - Patient is pregnant or breast-feeding - Patient has signs of decompensated chronic hepatitis B Other protocol-defined exclusion criteria may apply.


NCT ID:

NCT00124241


Primary Contact:

N/A


Backup Contact:

N/A


Location Contact:

Los Angeles, California
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: December 17, 2017

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.